MULTI-G
MULTI-G has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.81M and a net result of €438k. Equity is growing by ~24.1% per year across the filed fiscal years. Its solvency ranks better than 54% of 9900 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
| Equity | €1.81M |
| Net result | €438k |
| Staff (FTE) | 2.1 |
| Better than sector | 54% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 41.3% | 37.6% | |
| Net result | €438k | €31k | |
| Equity | €1.81M | €261k | |
| Gross operating margin | €1.12M | €227k | |
| Staff costs | €358k | €159k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Deposit | abbreviated schema | abbreviated schema | abbreviated schema | abbreviated schema |
| Revenue | - | - | €6.65M | - |
| EBITDA | €681k | €1.11M | €119k | €329k |
| Net profit | €438k | €546k | €21k | €65k |
| Cash flow | €492k | €592k | €68k | €120k |
| Staff costs | €358k | €325k | €316k | €238k |
| Income taxes | €205k | €324k | €13k | €28k |
| Dividends | €55k | €141k | €150k | - |
| Total assets | €4.38M | €5.23M | €4.12M | €3.78M |
| Equity | €1.81M | €1.43M | €884k | €1.01M |
| Debt | €2.57M | €3.80M | €3.24M | €2.76M |
| of which ≤ 1y | €2.50M | €3.76M | €3.21M | €2.73M |
| of which > 1y | €73k | €34k | €29k | €34k |
| Working capital | €1.66M | €1.28M | €693k | €789k |
| Employees (FTE) | 2.1 | 3.7 | 3.7 | 3.3 |
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Current ratio | 1.67 | 1.34 | 1.22 | 1.29 |
| Quick ratio | 1.56 | 1.31 | 1.18 | 1.21 |
| Working capital ratio | 38.0% | 24.4% | 16.8% | 20.9% |
| Solvency | 41.3% | 27.3% | 21.4% | 26.8% |
| Debt / equity | 1.42 | 2.66 | 3.67 | 2.73 |
| Long-term debt ratio | 0.04 | 0.02 | 0.03 | 0.03 |
| Interest coverage | 2.76 | 5.04 | 0.80 | 1.51 |
| Gross margin | - | - | 7.5% | - |
| Net margin | - | - | 0.3% | - |
| ROA | 10.0% | 10.4% | 0.5% | 1.7% |
| ROE | 24.2% | 38.2% | 2.3% | 6.4% |
| EBITDA margin | - | - | 1.8% | - |
| Days sales outstanding | - | - | 171d | - |
| Days payable outstanding | - | - | 120d | - |
| Inventory turnover | - | - | 50.43 | - |
| Days inventory (DSI) | - | - | 7d | - |
Full annual accounts (27 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €4.38M | €5.23M | €4.12M | €3.78M |
| Fixed assets | 21/28 | €221k | €186k | €219k | €258k |
| Intangible fixed assets | 21 | €15k | €22k | €28k | €31k |
| Tangible fixed assets | 22/27 | €193k | €152k | €168k | €203k |
| Financial fixed assets | 28 | €12k | €12k | €23k | €23k |
| Current assets | 29/58 | €4.16M | €5.04M | €3.91M | €3.52M |
| Stocks & contracts in progress | 3 | €273k | €109k | €122k | €224k |
| Amounts receivable within one year | 40/41 | €3.25M | €4.28M | €3.19M | €2.46M |
| Cash & bank | 54/58 | €228k | €196k | €107k | €368k |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €4.38M | €5.23M | €4.12M | €3.78M |
| Equity | 10/15 | €1.81M | €1.43M | €884k | €1.01M |
| Contributions / capital | 10/11 | €19k | €19k | €19k | €19k |
| Reserves | 13 | €1.78M | €1.40M | €769k | €748k |
| Accumulated profits (losses) | 14 | €11k | €11k | €96k | €246k |
| Amounts payable | 17/49 | €2.57M | €3.80M | €3.24M | €2.76M |
| Amounts payable after one year | 17 | €73k | €34k | €29k | €34k |
| Amounts payable within one year | 42/48 | €2.50M | €3.76M | €3.21M | €2.73M |
| Trade debts payable within one year | 44 | €1.21M | €2.07M | €2.01M | €1.60M |
| Income statement | |||||
| Turnover | 70 | - | - | €6.65M | - |
| Gross operating margin | 9900 | €1.12M | €1.58M | €519k | €596k |
| Operating result | 9901 | €627k | €1.06M | €72k | €274k |
| Financial income | 75 | €263k | €29k | €111k | €37k |
| Financial charges | 65 | €246k | €219k | €150k | €218k |
| Result before taxes | 9903 | €643k | €870k | €33k | €93k |
| Income taxes | 67/77 | €205k | €324k | €13k | €28k |
| Net result for the period | 9904 | €438k | €546k | €21k | €65k |
| Result to be appropriated | 9905 | €438k | €546k | €21k | €65k |
| NACE primary | Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses(47741) |
| Legal form | Private limited company(610) |
| Incorporation | 13-06-1990 |
| Status | Active |
| Postal code | 2018 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11806F1340/00X010 | Flanders | 244 m² | 1 · 98 m² | 11.0 m · 3 fl. |
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
31-08-2023 Capital decrease of €1,860 to €16,740
- €18.600 → €16.740
Technical details
{
"events": [
{
"kind": "statutory_reserve_release",
"after_eur": 16740.0,
"delta_eur": -1860.0,
"before_eur": 18600.0,
"decrease_purpose": null,
"contribution_type": "reserves_incorporation",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "suppress"
}
],
"notary": {
"name": "Jean Jacques LECLEF",
"firm_city": null,
"firm_name": null,
"office_city": "Antwerpen",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-08-31",
"filing_date": "2023-08-21",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2023-07-11",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0441.139.667",
"name_full": "MULTI-G",
"legal_form": "BESLOTEN VENNOOTSCHAP",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Jean Jacques LECLEF",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"Een voor eensluidend verklaard afschrift van het proces-verbaal van de buitengewone algemene vergadering",
"Geco\u00F6rdineerde statuten"
],
"shareholders_after": [
{
"kbo": null,
"pct": 100.0,
"kind": "person",
"name": "ZOHORI Gad",
"role": "aandeelhouder",
"n_shares": 750,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "SCH\u00D6NBERGER, Rose Anne",
"role": "aandeelhouder",
"n_shares": null,
"share_class": null
}
],
"share_classes_after": []
}| Legal nameNL | MULTI-G |